Reducing mold exposure in New York City public housing to improve asthma symptoms
Mold Policy Intervention in New York City Public Housing and Asthma Morbidity
This study is testing a new program called 'Mold Busters' to help reduce mold in public housing in New York City, with the goal of making life easier for residents, especially those with asthma who are sensitive to mold.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10877085 on NIH RePORTER |
What this research studies
This research investigates the impact of a new program called 'Mold Busters' aimed at reducing mold in public housing in New York City. The program focuses on improving mold remediation through better assessment tools, staff training, and accountability measures. By addressing the root causes of mold growth in lower-income urban homes, the study aims to decrease asthma symptoms among residents, particularly those who are allergic to mold. The research will evaluate the effectiveness of these interventions in reducing asthma exacerbations and improving overall health outcomes for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adults living in New York City public housing who suffer from asthma and are exposed to mold.
Not a fit: Patients living in private housing or those without asthma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in asthma symptoms and hospital visits for residents living in mold-affected public housing.
How similar studies have performed: Previous interventions targeting mold remediation in urban settings have shown promise in improving asthma outcomes, indicating that this approach is grounded in successful methodologies.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Perzanowski, Matthew S — Columbia University Health Sciences
- Study coordinator: Perzanowski, Matthew S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.